Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nocebo Effecten Verminderen in Kinderen Met ADHD: the NOVA Study

NCT06797570 is registered in ClinicalTrials.gov with St. Antonius Hospital as lead sponsor.

NCT NCT06797570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06797570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nocebo Effecten Verminderen in Kinderen Met ADHD: the NOVA Study
Lead sponsor
St. Antonius Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 25, 2025
Completion date
January 6, 2027
Enrollment
130 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

add, adhd, adhd or adhd traits, adhd predominantly hyperactivity type, adhd predominantly inattentive type, adhd with sleep onset insomnia, adhd, add, adhd, predominantly hyperactive - impulsive, adhd, predominantly inattentive type, adhd-not other specified, attention deficit disorder, attention deficit disorder (add), attention deficit disorder with hyperactivity, hyperactivity, hyperactivity disorder, inattention